Koninklijke DSM (OTCMKTS:RDSMY – Get Free Report) and BioLargo (NASDAQ:BLGO – Get Free Report) are both basic materials companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, dividends, profitability, earnings, analyst recommendations, risk and valuation.
Risk & Volatility
Koninklijke DSM has a beta of 1, indicating that its share price has a similar volatility profile to the S&P 500.Comparatively, BioLargo has a beta of 0.18, indicating that its share price is 82% less volatile than the S&P 500.
Profitability
This table compares Koninklijke DSM and BioLargo’s net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
Koninklijke DSM | N/A | N/A | N/A |
BioLargo | -16.53% | -58.35% | -32.12% |
Insider & Institutional Ownership
Valuation and Earnings
This table compares Koninklijke DSM and BioLargo”s revenue, earnings per share (EPS) and valuation.
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
Koninklijke DSM | $10.89 billion | 2.17 | $1.98 billion | N/A | N/A |
BioLargo | $12.23 million | 5.81 | -$3.50 million | ($0.03) | -7.97 |
Koninklijke DSM has higher revenue and earnings than BioLargo.
Analyst Recommendations
This is a summary of current recommendations and price targets for Koninklijke DSM and BioLargo, as provided by MarketBeat.com.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Koninklijke DSM | 0 | 0 | 0 | 0 | N/A |
BioLargo | 0 | 0 | 0 | 0 | N/A |
Summary
Koninklijke DSM beats BioLargo on 7 of the 9 factors compared between the two stocks.
About Koninklijke DSM
Koninklijke DSM N.V., a science-based company, engages in nutrition, health, and sustainable living businesses in the Netherlands, Switzerland, rest of Europe, North America, Latin America, China, rest of Asia, and internationally. It operates through Nutrition, Materials, and Innovation Center segments. The Nutrition segment offers animal nutrition and health products, including vitamins, premixes, carotenoids, enzymes, microbes, and eubiotics; human nutrition and health products comprising vitamins, nutritional lipids, minerals, carotenoids, nutraceuticals, digestive enzymes, probiotics, and prebiotics, as well as active pharmaceutical ingredients; premix, market-ready solutions, and personalized nutrition; human milk oligosaccharides; and skin and sun care, hair care, and aroma ingredients; omega-3 fatty acids; and specialty food enzymes, cultures, bio-preservation, texturizing hydrocolloids, sugar reduction, and savory taste solutions. The Materials segment provides specialty plastics used in components for the electrical and electronics, automotive, flexible food-packaging, and consumer goods industries; and Dyneema, a fiber solution for use in personal protection, workwear, sports apparel, outdoor equipment, ropes and slings, synthetic chains, and nets for the aquaculture, and renewable energy sectors. The Innovation Center segment offers biomedical materials, and medical device and material manufacturing technologies in the areas of cardiovascular, continence care, dental, diabetes management, gynecology, neurology, ophthalmology, orthopedic, peripheral vascular, plastic and reconstructive surgery, and wound management. It also commercializes yeast technology yeast for ethanol production. The company was founded in 1902 and is headquartered in Heerlen, the Netherlands.
About BioLargo
BioLargo, Inc. invents, develops, and commercializes various platform technologies. Its technologies solve challenging environmental problems comprising per – and polyfluoroalkyl substances (PFAS) water contamination, advanced water and wastewater treatment, industrial odor and volatile organic compounds control, air quality control, infection control, and myriad environmental remediation. The company provides full-service environmental engineering services. BioLargo, Inc. was incorporated in 1991 and is based in Westminster, California.
Receive News & Ratings for Koninklijke DSM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Koninklijke DSM and related companies with MarketBeat.com's FREE daily email newsletter.